Atlas Trials

Plaque Type Psoriasis

14 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Plaque Type Psoriasis

RecordFirmDate
MSB11022 in Moderate to Severe Chronic Plaque Psoriasis (NCT02660580)Fresenius Kabi SwissBioSim GmbH2016-02-16
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira (NCT02016105)Sandoz2013-12-01
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-012) (NCT01936688)Sun Pharmaceutical Industries Limited2013-09-01
Judging the Efficacy of Secukinumab in Patients With Psoriasis Using AutoiNjector: a Clinical Trial Evaluating Treatment Results (JUNCTURE) (NCT01636687)Novartis Pharmaceuticals2012-10-17
Efficacy and Safety of Intravenous and Subcutaneous Secukinumab in Moderate to Severe Chronic Plaque-type Psoriasis (NCT01412944)Novartis Pharmaceuticals2011-12-01
Safety Study of Ointment for the Treatment of Plaque-type Psoriasis (NCT01258088)Pfizer2010-11-30
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis (NCT01132612)Novartis Pharmaceuticals2010-05-11
A Study to Evaluate the Efficacy and Tolerability of Topical Therapies for the Condition of Plaque-Type Psoriasis (NCT00852761)Stiefel, a GSK Company2009-03-01
Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of CD 2027 Spray in Adults With Plaque-type Psoriasis (NCT00763503)Galderma R&D2008-09-01
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study) (NCT00773734)Amgen2008-09-01
Study of Dose-Effect of COL-121 Ointment in Patients With Plaque-Type Psoriasis (NCT00625326)Deltanoid Pharmaceuticals2008-01-01
Apremilast Safety and PK Study in Recalcitrant Plaque Psoriasis (NCT00521339)Amgen2007-08-01
n-3 Polysaturated Fatty Acids-rich Diet in Psoriasis (NCT01876875)Federico II University2007-04-01

Track Plaque Type Psoriasis automatically

Every clearance here is in the API, with alerts when new ones post.